<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">eifc</journal-id><journal-title-group><journal-title xml:lang="ru">Эпизоотология Иммунобиология Фармакология Санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Epizootology Immunobiology Pharmacology Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-168X</issn><publisher><publisher-name>Институт экспериментальной ветеринарии им. С.Н. Вышелесского</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">eifc-64</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИММУНОБИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>IMMUNOBIOLOGY</subject></subj-group></article-categories><title-group><article-title>Вероятная связь миелоидного и лимфобластного лейкоза с туберкулезной инфекцией</article-title><trans-title-group xml:lang="en"><trans-title>Probable link between myeloid and lymphoblastic leukemia with tuberculosis infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лысенко</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Lysenko</surname><given-names>A. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Broxmeye</surname><given-names>L. ..</given-names></name><name name-style="western" xml:lang="en"><surname>Broxmeyer</surname><given-names>L. ..</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власенко</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasenko</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кучвальский</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuchvalsky</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Красникова</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Krasnikova</surname><given-names>E. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>РУП «Институт экспериментальной ветеринарии им. С.Н. Вышелесского»</institution><country>Russian Federation</country></aff><aff xml:lang="en" id="aff-2"><institution>N.Y. Institute of Medical Research in Bayside</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>Винницкий национальный аграрный университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2020</year></pub-date><volume>0</volume><issue>1</issue><fpage>23</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лысенко А.П., Broxmeye L..., Власенко В.В., Кучвальский М.В., Красникова Е.Л., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Лысенко А.П., Broxmeye L..., Власенко В.В., Кучвальский М.В., Красникова Е.Л.</copyright-holder><copyright-holder xml:lang="en">Lysenko A.P., Broxmeyer L..., Vlasenko V.V., Kuchvalsky M.V., Krasnikova E.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://eifc.belal.by/jour/article/view/64">https://eifc.belal.by/jour/article/view/64</self-uri><abstract><p>Из перевиваемых миелобластов человека, больного острым миелоидным лейкозом (Kasumi-1), и Т-лимфоцитов больного Т-лимфобластной лейкемией (Jurkat), в том числе из 0.22 µm фильтратов их лизатов, выделены микобактерии туберкулеза (МБТ) с дефектной клеточной стенкой (cell wall deficient - СWD) с одинаковым антигенным составом. Изоляты обладали уникальными свойствами, после разрушения ультразвуком и фильтрации через Amicon Ultracel® 100 K и Millex® GP 0.22 µm их фильтраты давали рост CWD МБТ, имевшими одинаковый антигенный состав, в том числе с исходными изолятами. Основную роль в выделении CWD МБТ играла инкубация исследуемого материала в стимуляторе роста, посев на специальную питательную среду и «слепые» пересевы.</p></abstract><trans-abstract xml:lang="en"><p>From the cultures cells of myeloblasts of the human patient with acute myeloid leukemia (Kasumi-1) and T-lymphocytes the patient with T-lymphoblastic leukemia (Jurkat) including from 0.22 µm filtrates of cells lysates there are isolated mycobacteria of tuberculosis (MBT) with deficient cell wall (cell wall deficient - CWD) with the same of antigens composition. Isolates had a number of unique properties. After destruction by ultrasound and filtration through Amicon Ultracel® 100 K and Millex ® GP 0.22 µm their filtrates gave growth of CWD MBT having the same antigenic composition, including starting isolates. The main role in the isolation of CWD MBT was the incubation of the test material in the growth stimulants, sowing on a special nutrient medium and «blind» passages.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
